XBI holdings
State Street SPDR S&P Biotech ETF
Positions
161 stored of 161 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 101 | Avalo Therapeutics Inc | US05338F3064 | 05338F306 | 0.349% | $37.5M | Equity (common) | Corporate | United States | USD |
| 102 | MannKind Corp | US56400P7069 | 56400P706 | 0.338% | $36.3M | Equity (common) | Corporate | United States | USD |
| 103 | Annexon Inc | US03589W1027 | 03589W102 | 0.332% | $35.6M | Equity (common) | Corporate | United States | USD |
| 104 | ORIC Pharmaceuticals Inc | US68622P1093 | 68622P109 | 0.329% | $35.4M | Equity (common) | Corporate | United States | USD |
| 105 | Zenas Biopharma Inc | US98937L1052 | 98937L105 | 0.319% | $34.2M | Equity (common) | Corporate | United States | USD |
| 106 | Jade Biosciences Inc | US0080642061 | 008064206 | 0.317% | $34.1M | Equity (common) | Corporate | United States | USD |
| 107 | Kura Oncology Inc | US50127T1097 | 50127T109 | 0.317% | $34.1M | Equity (common) | Corporate | United States | USD |
| 108 | Olema Pharmaceuticals Inc | US68062P1066 | 68062P106 | 0.317% | $34.0M | Equity (common) | Corporate | United States | USD |
| 109 | CareDx Inc | US14167L1035 | 14167L103 | 0.304% | $32.6M | Equity (common) | Corporate | United States | USD |
| 110 | Bicara Therapeutics Inc | US0554771032 | 055477103 | 0.303% | $32.6M | Equity (common) | Corporate | United States | USD |
| 111 | Vor BioPharma Inc | US9290332074 | 929033207 | 0.301% | $32.3M | Equity (common) | Corporate | United States | USD |
| 112 | Xencor Inc | US98401F1057 | 98401F105 | 0.291% | $31.2M | Equity (common) | Corporate | United States | USD |
| 113 | ArriVent Biopharma Inc | US04272N1028 | 04272N102 | 0.285% | $30.6M | Equity (common) | Corporate | United States | USD |
| 114 | Replimune Group Inc | US76029N1063 | 76029N106 | 0.284% | $30.5M | Equity (common) | Corporate | United States | USD |
| 115 | CytomX Therapeutics Inc | US23284F1057 | 23284F105 | 0.278% | $29.9M | Equity (common) | Corporate | United States | USD |
| 116 | Janux Therapeutics Inc | US47103J1051 | 47103J105 | 0.276% | $29.6M | Equity (common) | Corporate | United States | USD |
| 117 | Sionna Therapeutics Inc | US8294011080 | 829401108 | 0.265% | $28.5M | Equity (common) | Corporate | United States | USD |
| 118 | Geron Corp | US3741631036 | 374163103 | 0.260% | $27.9M | Equity (common) | Corporate | United States | USD |
| 119 | Solid Biosciences Inc | US83422E2046 | 83422E204 | 0.240% | $25.8M | Equity (common) | Corporate | United States | USD |
| 120 | Rigel Pharmaceuticals Inc | US7665597024 | 766559702 | 0.237% | $25.4M | Equity (common) | Corporate | United States | USD |
| 121 | Allogene Therapeutics Inc | US0197701065 | 019770106 | 0.235% | $25.3M | Equity (common) | Corporate | United States | USD |
| 122 | Sana Biotechnology Inc | US7995661045 | 799566104 | 0.230% | $24.7M | Equity (common) | Corporate | United States | USD |
| 123 | Altimmune Inc | US02155H2004 | 02155H200 | 0.229% | $24.6M | Equity (common) | Corporate | United States | USD |
| 124 | REGENXBIO Inc | US75901B1070 | 75901B107 | 0.219% | $23.5M | Equity (common) | Corporate | United States | USD |
| 125 | Ironwood Pharmaceuticals Inc | US46333X1081 | 46333X108 | 0.216% | $23.2M | Equity (common) | Corporate | United States | USD |
| 126 | Immix Biopharma Inc | US45258H1068 | 45258H106 | 0.202% | $21.7M | Equity (common) | Corporate | United States | USD |
| 127 | Ocugen Inc | US67577C1053 | 67577C105 | 0.199% | $21.4M | Equity (common) | Corporate | United States | USD |
| 128 | 4D Molecular Therapeutics Inc | US35104E1001 | 35104E100 | 0.199% | $21.4M | Equity (common) | Corporate | United States | USD |
| 129 | Candel Therapeutics Inc | US1374041093 | 137404109 | 0.194% | $20.8M | Equity (common) | Corporate | United States | USD |
| 130 | Savara Inc | US8051111016 | 805111101 | 0.183% | $19.7M | Equity (common) | Corporate | United States | USD |
| 131 | Prime Medicine Inc | US74168J1016 | 74168J101 | 0.180% | $19.3M | Equity (common) | Corporate | United States | USD |
| 132 | First Tracks Biotherapeutics Inc | US3371851029 | 337185102 | 0.174% | $18.7M | Equity (common) | Corporate | United States | USD |
| 133 | Damora Therapeutics Inc | US36322Q2066 | 36322Q206 | 0.173% | $18.6M | Equity (common) | Corporate | United States | USD |
| 134 | ARS Pharmaceuticals Inc | US82835W1080 | 82835W108 | 0.171% | $18.3M | Equity (common) | Corporate | United States | USD |
| 135 | MapLight Therapeutics Inc | US56565P1030 | 56565P103 | 0.166% | $17.9M | Equity (common) | Corporate | United States | USD |
| 136 | Arbutus Biopharma Corp | CA03879J1003 | 03879J100 | 0.164% | $17.6M | Equity (common) | Corporate | Canada | USD |
| 137 | Myriad Genetics Inc | US62855J1043 | 62855J104 | 0.160% | $17.2M | Equity (common) | Corporate | United States | USD |
| 138 | Cabaletta Bio Inc | US12674W1099 | 12674W109 | 0.152% | $16.3M | Equity (common) | Corporate | United States | USD |
| 139 | Compass Therapeutics Inc | US20454B1044 | 20454B104 | 0.140% | $15.0M | Equity (common) | Corporate | United States | USD |
| 140 | Emergent BioSolutions Inc | US29089Q1058 | 29089Q105 | 0.133% | $14.3M | Equity (common) | Corporate | United States | USD |
| 141 | Prothena Corp PLC | IE00B91XRN20 | Not reported | 0.133% | $14.2M | Equity (common) | Corporate | Ireland | USD |
| 142 | Vanda Pharmaceuticals Inc | US9216591084 | 921659108 | 0.131% | $14.0M | Equity (common) | Corporate | United States | USD |
| 143 | Perspective Therapeutics Inc | US46489V3024 | 46489V302 | 0.128% | $13.8M | Equity (common) | Corporate | United States | USD |
| 144 | Ovid therapeutics Inc | US6904691010 | 690469101 | 0.123% | $13.2M | Equity (common) | Corporate | United States | USD |
| 145 | Verastem Inc | US92337C2035 | 92337C203 | 0.121% | $12.9M | Equity (common) | Corporate | United States | USD |
| 146 | MiMedx Group Inc | US6024961012 | 602496101 | 0.106% | $11.4M | Equity (common) | Corporate | United States | USD |
| 147 | Lexeo Therapeutics Inc | US52886X1072 | 52886X107 | 0.105% | $11.3M | Equity (common) | Corporate | United States | USD |
| 148 | Achieve Life Sciences Inc | US0044685008 | 004468500 | 0.082% | $8.8M | Equity (common) | Corporate | United States | USD |
| 149 | Sagimet Biosciences Inc | US7867001049 | 786700104 | 0.071% | $7.6M | Equity (common) | Corporate | United States | USD |
| 150 | CONTRA METSERA INC | Not reported | 592CVR013 | 0.070% | $7.5M | Equity derivatives | Other | United States | USD |
| 151 | BridgeBio Oncology Therapeutics Inc | US1079241022 | 107924102 | 0.058% | $6.2M | Equity (common) | Corporate | United States | USD |
| 152 | State Street Global Advisors State Street Institutional US Government Money Market Fund | US8574927062 | 857492706 | 0.040% | $4.3M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 153 | CONTRA AKERO THERAPEUT | US009CVR0445 | 009CVR044 | 0.012% | $1.3M | Equity derivatives | Other | United States | USD |
| 154 | CONTRA INHIBRX INC | US457CVR0178 | 457CVR017 | 0.010% | $1.1M | Equity derivatives | Other | United States | USD |
| 155 | CONTRA MIRATI THERAPEU | Not reported | 604CVR027 | 0.009% | $959K | Equity derivatives | Other | United States | USD |
| 156 | CONTRA VERVE THERAPEUT | US925CVR0115 | 925CVR011 | 0.005% | $567K | Equity derivatives | Other | United States | USD |
| 157 | CONTRA BLUEPRINT MEDIC | US096CVR0480 | 096CVR048 | 0.003% | $348K | Equity derivatives | Other | United States | USD |
| 158 | State Street Global Advisors State Street Institutional US Government Money Market Fund | US8574927062 | 857492706 | <0.001% | $5K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 159 | Atrium Therapeutics Inc | US04965N1046 | 04965N104 | 0.000% | $7 | Equity (common) | Corporate | United States | USD |
| 160 | OMNIAB INC | US68218J2024 | 68218J202 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |
| 161 | OMNIAB INC | US68218J3014 | 68218J301 | 0.000% | $0 | Equity (common) | Corporate | United States | USD |